Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

DNA Damage Can Stall the Cell Cycle

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A pilot study investigating the comparison of immunological responses to two immunosuppressive regimens in a porcine model.

Frontiers in veterinary science·2026

Same author

A catalogue of missense and nonsense mutation abundances for the U.S. cancer patient population.

medRxiv : the preprint server for health sciences·2026

Same author

Transcriptional regulatory network analysis uncovers modular gene control and potential key regulators in diabetic cardiomyopathy.

Frontiers in cell and developmental biology·2026

Same author

Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round.

Stem cell reports·2026

Same author

A Tri-Culture Heart-on-a-Chip Platform With iPSC-Derived Cardiac Cells for Predictive Cardiotoxicity Testing.

Advanced healthcare materials·2026

Same author

Protocadherin 20 Is a POU Class 2 Homeobox 3 Target Gene Required for Proper Tuft Cell Microvillus Organization.

Cellular and molecular gastroenterology and hepatology·2026

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Linking the p53 tumour suppressor pathway to somatic cell reprogramming.

Teruhisa Kawamura¹, Jotaro Suzuki, Yunyuan V Wang

¹Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA.

|August 12, 2009

Summary

Scientists found that inhibiting the p53 pathway significantly boosts the efficiency of creating induced pluripotent stem (iPS) cells from somatic cells. This discovery enhances reprogramming methods and reduces cancer risks.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

Related Experiment Videos

Last Updated: Jun 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

Area of Science:

Cell Biology
Stem Cell Research
Molecular Biology

Background:

Induced pluripotent stem (iPS) cell generation is crucial for regenerative medicine.
Current reprogramming methods using pluripotency factors and oncogenes suffer from low efficiency and malignant transformation risks.
The p53 pathway's role in limiting somatic cell reprogramming efficiency is not fully understood.

Purpose of the Study:

To investigate the mechanisms limiting somatic cell reprogramming efficiency.
To identify strategies for enhancing iPS cell generation while minimizing oncogene use and malignant transformation.
To explore the role of the p53 pathway in the reprogramming process.

Main Methods:

Investigated the activation of the p53 pathway during reprogramming.
Reduced p53 signaling by expressing a mutated negative regulator, deleting/knocking down p53 or p21, or antagonizing apoptosis.
Assessed reprogramming efficiency in mouse and human somatic cells.

Main Results:

Reprogramming factors activate the p53 pathway, limiting efficiency.
Reducing p53 signaling significantly increased reprogramming efficiency in mouse fibroblasts.
Decreased p53 levels allowed iPS cell generation using only Oct4 and Sox2, producing germline-transmitting chimaeric mice.
Silencing p53 markedly enhanced human somatic cell reprogramming efficiency.

Conclusions:

The p53 pathway is a key barrier to efficient somatic cell reprogramming.
Inhibiting p53 signaling offers a novel strategy to improve iPS cell generation efficiency.
This approach provides a safer and more effective method for generating iPS cells, with potential clinical applications.